Humatrope



Indications and Reactions:

Role Indications Reactions
Primary
Growth Hormone Deficiency 34.2%
Hypopituitarism 21.4%
Drug Use For Unknown Indication 4.4%
Body Height Below Normal 4.1%
Growth Retardation 3.8%
Hypothyroidism 3.7%
Hypertension 3.4%
Dwarfism 3.0%
Turner's Syndrome 3.0%
Pituitary Tumour 2.8%
Adrenal Insufficiency 2.6%
Hypothalamo-pituitary Disorder 2.5%
Hormone Replacement Therapy 2.0%
Blood Growth Hormone 1.4%
Depression 1.4%
Blood Growth Hormone Decreased 1.3%
Pain 1.3%
Immunosuppressant Drug Therapy 1.2%
Prophylaxis 1.2%
Secondary Hypothyroidism 1.2%
Hospitalisation 14.9%
Pharmaceutical Product Complaint 8.8%
Vomiting 6.9%
Weight Increased 6.4%
Epiphysiolysis 5.9%
Death 5.6%
Weight Decreased 5.3%
Visual Acuity Reduced 5.1%
Pituitary Tumour Recurrent 4.0%
Pneumonia 4.0%
Convulsion 3.7%
Obstructive Airways Disorder 3.7%
Brain Neoplasm 3.5%
Loss Of Consciousness 3.5%
Pituitary Tumour Benign 3.5%
Drug Dose Omission 3.2%
No Adverse Event 3.2%
Surgery 3.2%
Neoplasm 2.9%
Neoplasm Recurrence 2.9%
Secondary
Growth Hormone Deficiency 34.1%
Hypopituitarism 17.1%
Drug Use For Unknown Indication 4.7%
Adrenal Insufficiency 4.1%
Hypothyroidism 3.7%
Hypertension 3.5%
Cardiac Failure Congestive 3.1%
Growth Retardation 3.1%
Insomnia 3.1%
Dwarfism 2.9%
Osteoporosis 2.7%
Product Used For Unknown Indication 2.5%
Essential Hypertension 2.3%
Hypogonadism 2.3%
Secondary Hypothyroidism 2.3%
Type 2 Diabetes Mellitus 2.3%
Immunosuppressant Drug Therapy 1.7%
Hypercholesterolaemia 1.6%
Hyperuricaemia 1.6%
Hyperlipidaemia 1.4%
Weight Increased 15.8%
Epiphysiolysis 7.9%
Vomiting 7.9%
Oesophageal Carcinoma 6.5%
Visual Acuity Reduced 5.8%
White Blood Cell Count Increased 5.8%
Pituitary Tumour Benign 5.0%
Scoliosis 4.3%
Testicular Pain 4.3%
Weight Decreased 4.3%
Hepatic Adenoma 3.6%
No Adverse Event 3.6%
Paraesthesia 3.6%
Stomach Discomfort 3.6%
Visual Impairment 3.6%
Fatigue 2.9%
Hospitalisation 2.9%
Incorrect Dose Administered 2.9%
Off Label Use 2.9%
Pain 2.9%
Concomitant
Drug Use For Unknown Indication 31.4%
Product Used For Unknown Indication 15.2%
Diabetes Mellitus 7.6%
Growth Hormone Deficiency 4.8%
Hypopituitarism 4.8%
Diabetes Mellitus Non-insulin-dependent 3.8%
Attention Deficit/hyperactivity Disorder 2.9%
Body Height Below Normal 2.9%
Crohn's Disease 2.9%
Fibromyalgia 2.9%
Psoriatic Arthropathy 2.9%
Type 2 Diabetes Mellitus 2.9%
Blood Growth Hormone Abnormal 1.9%
Blood Triglycerides Increased 1.9%
Bone Pain 1.9%
Breakthrough Pain 1.9%
Computerised Tomogram Abdomen 1.9%
High Density Lipoprotein Decreased 1.9%
Obesity 1.9%
Pain 1.9%
Vomiting 13.8%
Migraine 6.9%
Nausea 6.9%
Rash Maculo-papular 6.9%
Throat Irritation 6.9%
Toothache 6.9%
Urticaria 6.9%
Astrocytoma 3.4%
Chest Pain 3.4%
Chronic Myelomonocytic Leukaemia 3.4%
Decreased Appetite 3.4%
Diarrhoea 3.4%
Drug Effect Decreased 3.4%
Dry Skin 3.4%
Epistaxis 3.4%
Injection Site Haematoma 3.4%
Injection Site Pain 3.4%
Injection Site Pruritus 3.4%
Irritability 3.4%
Left Ventricular Hypertrophy 3.4%